April 2022
1. YAMAGUCHI S, Narukawa M
   Combinations of drug candidate properties affecting development success and discontinuation for five diseases: Lymphoma, non-small cell lung cancer, arthritis, depression, and Alzheimer's disease.
   J Clin Pharmacol. 2022 Apr 14. doi: 10.1002/jcph.2063.
   

   >> Share

   
   March 2022
2. MURALIDHARAN KK, Karumanchi S, Kowalski KG, Burkett P, et al
   A time-to-event exposure-response model for amyloid-related imaging abnormalities following administration of aducanumab to subjects with early alzheimer's disease.
   J Clin Pharmacol. 2022 Mar 14. doi: 10.1002/jcph.2047.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share